肺癌

有意团购印度易瑞沙 印度特罗凯 印度力比泰 请加入我们的群
官方QQ群1：26438631  5100806  或QQ:3 5 7 6 8 7 5 注明 www.feiai88.com！

　1、预防肺癌关键 是远离烟草（包括被动吸烟 二手烟）
    不吸烟、戒烟、远离二手烟污染和保持好心情是最好的预防手段。同时重视房屋的绿色装修、厨房的抽风设施和科学的烹调方法，注意职业保护、改善空气污染、治理环境污染
    2、早期诊断很重要
    成年人每年要常规参加健康体检，健康体检时一定要行胸片正侧位检查，有吸烟史30年的烟民最好行胸部低剂量螺旋CT扫描，有助于早期发现。
    同时重视肺癌的临床症状如刺激性咳嗽、血痰、胸痛、声音嘶哑等
　　3、得了肺癌一定要科学就医
    不要相信“伪科学”！一旦确诊肺癌后，一定要到正规的医院就诊，最好到到地区肺癌诊疗中心或三家医院的胸外科、肿瘤科和呼吸科就诊。千万不要相信什么“祖传秘方”和“特异功能”之类的伪科学，也不要将希望寄托在那些保健品上。要科学理智地进行医疗消费。
    4、确诊肺癌 一定要先分期、后治疗 
    肺癌治疗前必须要做胸部CT、颅脑核磁、纤维支气管镜检查、全身骨扫描、腹部超声或腹部CT、血液肿瘤标记物！明确临床分期后再开始治疗，除外肺外转移后再决定手术治疗！千万不要“急诊”手术！因为不同分期的肺癌治疗策略不一样，治疗效果也不一样。
　　5、外科手术有适应症
    I期、II期和IIIa期非小细胞肺癌可以从外科手术中获得益处，IV期肺癌则原则上不应进行外科手术。近年来，随着微创胸外科技术的普及和有效的化疗药物以及靶向药物的应用，肺癌扩大切除手术已经不再提倡。详情可登陆相关肺癌中心和专业学会网站。
    6、肺癌化疗有一线化疗和二线化疗之分
    一线化疗药物：诺维本 泰素、健择和泰索帝 加铂类药物（铂尔定和顺铂），二线化疗药物：泰索帝 力比泰 易瑞沙（团购印度易瑞沙 印度特罗凯 印度力比泰）和特罗凯（团购印度易瑞沙 印度特罗凯 印度力比泰）。化疗同时应用凯特瑞等药物可防治化疗药物所致的恶心和呕吐，惠尔血等药物可纠正化疗所致的骨髓抑制出现的白细胞下降。
    7、肺癌放疗技术大有进步
    有适形调强放疗、伽马刀、X-刀等新技术。
    8、靶向治疗创奇迹
    近年来靶向治疗药物为成千上万的中国非小细胞肺癌患者带来了福音。易瑞沙在中国上市已整整三年，特罗凯在中国上市也整整一年。给化疗治疗失败的患者、不能够耐受化疗的中老年肺癌患者带来生的希望。希望医保部门尽快启动“绿色通道”，将其纳入医保报销目录。
    9、慎重选用肺癌治疗新技术
    近年来一些投资商在各大医院投资购进了肺癌治疗新设备，用商业手段吸引各大医院肿瘤科为其介绍肺癌患者。其中绝大多数是肿瘤专家把关，少数医疗机构就是以赚钱为目的，没有专业的肿瘤医生，综合治疗手段没有，医疗质量没有保障。请大家慎重选用所谓的“新技术”。
　　10、肺癌强调多学科综合治疗
    随着对肿瘤细胞生物学的认识、临床资料和临床经验的不断积累，肺癌领域专家学者更多强调肺癌要多学科综合治疗！小细胞肺癌是以化疗为主的多学科综合治疗，局部早中期非小细胞肺癌是以外科手术为主的多学科综合治疗。近年来临床研究结果表明：有效的术前新辅助化疗和术后辅助化疗可以延长非小细胞肺癌的五年生存率。

看过此文章的朋友还看过
团购靶向药活动开始                易瑞沙(IRESSA)中文说明
特罗凯(Tarceva)中文说明书        一个据称很管用的偏方

==== 汉译英 ====

1, the key is to prevent lung cancer from tobacco (including passive smoking, passive smoking)
    Non-smoking, quit smoking, stay away from secondhand smoke pollution and maintain the good mood is the best means of prevention. While focusing on green house decoration, kitchen ventilation facilities and scientific cooking methods, pay attention to job protection, reduce air pollution, environmental pollution
    2, early diagnosis is very important
    Adults to participate in an annual routine health check, health physical examination must take the positive lateral chest X-ray examination, smoking history of 30 years, smokers have the best line of low-dose spiral chest CT scan will help early detection.
    While focusing on lung cancer symptoms such as irritating cough, blood sputum, chest pain, hoarseness, etc.
3, got lung cancer, medical treatment was necessary to scientifically
    Do not believe the "pseudo-science"! Once the diagnosis of lung cancer, be sure to go to a regular hospital, it is best to to the regional lung cancer treatment centers or three hospitals thoracic surgery, oncology and Respiratory treatment. Do not believe in "traditional remedy" and "ESP" sort of pseudo-science, do not want to pin their hopes on those health care products. A scientific and rational manner for health care spending.
    4, diagnosed with lung cancer, we must first stages, after the treatment
    Treatment of lung cancer to be done before the chest CT, brain magnetic resonance imaging, fiberoptic bronchoscopy, whole body bone scan, abdominal ultrasound or abdominal CT, the blood tumor markers! Clear clinical stage after starting treatment, except for the decision-pulmonary metastasis after surgery! Do not "emergency" surgery! Because different stages of lung cancer treatment strategies are different not the same treatment.
5, there are indications for surgery
    I, II period and IIIa non-small cell lung cancer can benefit from the surgery, IV lung cancer is not, in principle should be carried out surgery. In recent years, with the popularity of minimally invasive thoracic surgical techniques and effective chemotherapy drugs and targeted drug application, expand the resection of lung cancer is no longer advocated. For details, please visit the relevant sites of lung cancer centers and professional societies.
    6, lung cancer, chemotherapy and second-line chemotherapy for first-line chemotherapy divided
    First-line chemotherapy drugs: Navelbine Taxol, Gemzar and Taxotere plus platinum drugs (cisplatin platinum Seoul set), second-line chemotherapy drugs: Taxotere Alimta Iressa and Tarceva. Application of chemotherapy drugs such as Kai Terui can prevent chemotherapy-induced nausea and vomiting, drugs such as G-CSF can correct chemotherapy-induced leukopenia and bone marrow suppression occurs.
    7, a significant improvement of lung cancer radiotherapy
    There conformal intensity modulated radiotherapy, Gamma Knife, X-knife and other new technologies.
    8, targeted therapy miracles
    In recent years, targeted therapies for the thousands of Chinese non-small cell lung cancer has brought the gospel. Iressa has been listed in China, a full three years, Tarceva is also listed in China, a whole year. To the chemotherapy treatment failure patients can not tolerate chemotherapy in elderly lung cancer patients, hygiene hope. Medical Insurance Department hopes to start as soon as possible "green channel" will be included in medical insurance reimbursement directory.
    9, and carefully selected new technologies, treatment of lung cancer
    In recent years, some investors had invested in the major hospitals, the purchase of new equipment, treatment of lung cancer, using commercial means to attract major hospitals, oncology referral to patients with lung cancer. Most of them oncologists check, a small number of medical institutions is to make money for the purpose of tumor no professional doctors, there is no comprehensive treatment, medical quality are not guaranteed. Please carefully select the so-called "new technology."
10, lung cancer, emphasis on multidisciplinary comprehensive treatment
    With the understanding of tumor cell biology, clinical data and clinical experience is gained, lung cancer, experts and scholars in the field should be greater emphasis on multidisciplinary treatment of lung cancer! Small-cell lung cancer is a chemotherapy-based multidisciplinary treatment, the early and middle part is based on non-small cell lung cancer surgery based multi-disciplinary comprehensive treatment. In recent years, clinical results show that: effective preoperative neoadjuvant chemotherapy and postoperative adjuvant chemotherapy for non-small cell lung cancer can be extended five-year survival rate.